Detalhe da pesquisa
1.
Three-Dimensional Microtumors for Probing Heterogeneity of Invasive Bladder Cancer.
Anal Chem
; 92(13): 8768-8775, 2020 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32579350
2.
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
Am J Pathol
; 185(5): 1385-95, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25907831
3.
Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase.
Proc Natl Acad Sci U S A
; 109(6): 1985-90, 2012 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22308318
4.
The transcription factor sex-determining region Y-box 2 (SOX2) in bladder cancer.
Am J Clin Exp Urol
; 12(2): 88-99, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38736621
5.
Characterization of laminin-332 gene expression in molecular subtypes of human bladder cancer.
Am J Clin Exp Urol
; 10(5): 311-319, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36313206
6.
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
Nat Commun
; 13(1): 6575, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323682
7.
Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
Prostate
; 71(2): 184-96, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20672321
8.
Intratumoral Heterogeneity Promotes Collective Cancer Invasion through NOTCH1 Variation.
Cells
; 10(11)2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34831307
9.
Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer.
Genome Biol
; 22(1): 105, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33858483
10.
Laminin-332-beta1 integrin interactions negatively regulate invadopodia.
J Cell Physiol
; 223(1): 134-42, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20039268
11.
Epitope mapping of function-blocking monoclonal antibody CM6 suggests a "weak" integrin binding site on the laminin-332 LG2 domain.
J Cell Physiol
; 223(3): 541-8, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20301201
12.
Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.
Oncogene
; 39(6): 1302-1317, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31636388
13.
Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
Sci Rep
; 9(1): 270, 2019 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670749
14.
Repression of transcription factor AP-2 alpha by PPARγ reveals a novel transcriptional circuit in basal-squamous bladder cancer.
Oncogenesis
; 8(12): 69, 2019 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31772149
15.
Cryptic fragment alpha4 LG4-5 derived from laminin alpha4 chain inhibits de novo adipogenesis by modulating the effect of fibroblast growth factor-2.
Dev Growth Differ
; 50(2): 97-107, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18067585
16.
Androgen represses opioid growth factor receptor (OGFR) in human prostate cancer LNCaP cells and OGFR expression in human prostate cancer tissue.
Am J Clin Exp Urol
; 6(4): 164-171, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30246052
17.
On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer.
Nat Rev Urol
; 14(2): 98-106, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27898096
18.
Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
Cancer Res
; 77(6): 1331-1344, 2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28108510
19.
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
Nat Commun
; 13(1): 7920, 2022 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564410
20.
FOXA1, GATA3 and PPARÉ£ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines.
Sci Rep
; 6: 38531, 2016 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27924948